The Wall Street Journal (12/5, B4, Cimilluca, Subscription Publication) reports that as part of its effort to expand its presence in the growing renal therapy market, Deerfield, Illinois-based Baxter International Inc. announced it has entered an agreement to acquire Lund, Sweden-based Gambro for 26.5 billion Swedish kronor ($4 billion). The Journal says Baxter is the world's second, and Gambro is world's third, biggest producer of kidney dialysis products and acute or chronic kidney disease therapies.
The Chicago Tribune (12/4, Frost) reports that Baxter CEO Robert Parkinson "told analysts in a conference call that the acquisition would allow it to grow Gambro's business in emerging and high-growth markets in countries like Brazil and China, where many patients with kidney failure go untreated."
The pending acquisition is also covered by the New York Times (12/5, Scott, Subscription Publication) "Dealbook" blog, theAP (12/5), Bloomberg News (12/5, Tirrell), Reuters (12/5, Sherman, Humer), Forbes (12/5, Japsen), theChicago Sun-Times (12/5, Knowles), and the Chicago Business Journal (12/4).
No comments:
Post a Comment